Avinger (NASDAQ:AVGR) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a report issued on Tuesday. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Price Performance

Shares of AVGR stock opened at $0.47 on Tuesday. Avinger has a 12-month low of $0.36 and a 12-month high of $4.37. The firm has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. The firm has a fifty day moving average of $0.52 and a 200-day moving average of $0.76.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.